-
1
-
-
58149191223
-
The writing committee on behalf of the ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study
-
Kitchener H, Swart AM, Qian Q, et al. The Writing Committee on Behalf of the ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125-136.
-
(2009)
Lancet
, vol.373
, pp. 125-136
-
-
Kitchener, H.1
Swart, A.M.2
Qian, Q.3
-
2
-
-
58149186453
-
The ASTEC/EN.5 Writing Committee on Behalf of the ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis
-
Blake P, Swart AM, Orton J, et al. The ASTEC/EN.5 Writing Committee on Behalf of the ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.
-
(2009)
Lancet
, vol.373
, pp. 137-146
-
-
Blake, P.1
Swart, A.M.2
Orton, J.3
-
3
-
-
18144432776
-
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma
-
Creutzberg CL, van Putten WLJ, Koper PCM, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404-1411.
-
(2000)
Lancet
, vol.355
, pp. 1404-1411
-
-
Creutzberg, C.L.1
Van Putten, W.L.J.2
Koper, P.C.M.3
-
4
-
-
63749130621
-
Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy
-
Kumar S, Shah JP, Bryant CS, et al. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy. Gynecol Oncol. 2009;113:233-239.
-
(2009)
Gynecol Oncol.
, vol.113
, pp. 233-239
-
-
Kumar, S.1
Shah, J.P.2
Bryant, C.S.3
-
5
-
-
34547842083
-
Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: A population-based study
-
van de Poll-Franse L, Mols F, Essink-Bot ML, et al. Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. Int J Radiat Oncol Biol Phys. 2007;69:125-132.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.69
, pp. 125-132
-
-
Van De Poll-Franse, L.1
Mols, F.2
Essink-Bot, M.L.3
-
6
-
-
1342321840
-
A phase III trial of surgery with our without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study
-
Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with our without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92: 744-751.
-
(2004)
Gynecol Oncol.
, vol.92
, pp. 744-751
-
-
Keys, H.M.1
Roberts, J.A.2
Brunetto, V.L.3
-
7
-
-
53749084414
-
Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomised PORTEC-2 trial
-
Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomised PORTEC-2 trial. J Clin Oncol. 2008;26:1010s.
-
(2008)
J Clin Oncol.
, vol.26
-
-
Nout, R.A.1
Putter, H.2
Jurgenliemk-Schulz, I.M.3
|